Showing results (1811-1820 of 2,288) with videos related to

Sort By:
Pageof 229
HIV Medicine|September 6, 2020
Body mass index and noninfectious comorbidity in HIV-positive patients commencing antiretroviral therapy in ZimbabweJ M Bleasel, J E Heron, T Shamu, et al.
HIV Medicine|September 9, 2020
Post-exposure prophylaxis in the era of pre-exposure prophylaxisM Atim, N Girometti, I Hyndman, et al.
HIV Medicine|March 14, 2020
Rate of dyslipidemia higher among women living with HIV: A comparison of metabolic and cardiovascular health in a cohort to study aging in HIVEab Russell, Ayk Albert, Hcf Côté, et al.
HIV Medicine|December 4, 2018
Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?C Gatey, A Brun, G Hamet, et al.
HIV Medicine|December 19, 2018
Uptake and virological outcomes of single- versus multi-tablet antiretroviral regimens among treatment-naïve youth in the HIV Research NetworkD C Griffith, C Farmer, K A Gebo, et al.
HIV Medicine|March 1, 2018
Monitoring HIV-indicator condition guided HIV testing in EstoniaK Rüütel, L Lemsalu, S Lätt, et al.
HIV Medicine|March 15, 2021
Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV-1-infected patients: a real-world study in JapanNaoki Kanda, Koh Okamoto, Hisatoshi Okumura, et al.
HIV Medicine|September 5, 2022
Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in GermanyChristian Hoffmann, Heiko Jessen, Christoph Wyen, et al.
HIV Medicine|November 22, 2018
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohortS Modica, B Rossetti, F Lombardi, et al.
HIV Medicine|November 23, 2021
IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence studyDominic Kaddu-Mulindwa, Lukas Keuser, Vadim Lesan, et al.
Pageof 229